The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
Open accessAbstract
Candida parapsilosis is becoming a predominant non-albicans cause of invasive candidiasis (IC). Echinocandins are the preferred choice for IC treatment and prophylaxis. Resistance to echinocandins in C. parapsilosis has emerged in several countries, but little is known about the susceptibility profile in China or about mechanisms of resistance. Here, we investigated the echinocandin susceptibilities of 2523 C. parapsilosis isolates collected from China and further explored the resistance mechanism among echinocandin-resistant isolates. Anidulafungin exhibited the highest MICs (MIC50/90, 1 and 2 µg/mL; GM, 0.948 µg/mL), while caspofungin showed better activity (0.5 and 1 µg/mL; 0.498 µg/mL). Significantly higher echinocandin MICs were observed among blood-derived isolates compared to others, especially for caspofungin (GM, 1.348 µg/mL vs 0.478 µg/mL). Isolates from ICU and surgical wards also showed higher MICs. Twenty isolates showed intermediate phenotypes for at least one echinocandin. One was resistant to all three echinocandins, fluconazole and voriconazole, which caused breakthrough IC during long-term exposure to micafungin. WGS revealed this isolate carried a mutation S656P in hotspot1 region of Fks1. Bioinformatics analyses suggested that this mutation might lead to an altered protein conformation. CRISPR Cas9-mediated introduction of this mutation into a susceptible reference C. parapsilosis strain increased MICs of all echinocandins 64-fold, with similar results found in the subspecies, C. orthopsilosis and C. metapsilosis. This is the first report of a multi-azole resistant and pan-echinocandin resistant C. parapsilosis isolate, and the identification of a FKS1S656P conferring pan-echinocandin resistance. Our study underscores the necessity of rigorous management of antifungal use and of monitoring for antifungal susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but there are also ample reports of individuals who experienced breakthrough infections while receiving an echinocandins.97,98”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [98]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Twelve years of SAMtools and BCFtools
Danecek, P., Bonfield, J. K., Liddle, J., Marshall, J., Ohan, V., Pollard, M. O., Whitwham, A., Keane, T., McCarthy, S. A., Davies, R. M., et al. (2021) · GigaScience · doi:10.1093/gigascience/giab008 · Cited by 15,343 · cited 1×
“4.3) [31,32].”
InfluentialCingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
The I-TASSER Suite: protein structure and function prediction
Yang, J., Yan, R., Roy, A., Xu, D., Poisson, J., & Zhang, Y. (2015) · Nature Methods · doi:10.1038/nmeth.3213 · Cited by 5,596 · cited 1×
“The three-dimensional (3D) models for protein structures of the Fks1 variants were obtained by modelling using the I-TASSER online server [36].”
MethodVarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,905 · cited 1×
“4.3) [31,32].”
InfluentialDeepTMHMM predicts alpha and beta transmembrane proteins using deep neural networks
Hallgren, J., Tsirigos, K. D., Pedersen, M. D., Almagro Armenteros, J. J., Marcatili, P., Nielsen, H., Krogh, A., & Winther, O. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.08.487609 · Cited by 1,499 · cited 1×
“Transmembrane helix predictions were performed with the DeepTHMMM bioinformatic tool [34].”
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202 · cited 1×
“lence of this pathogenic fungus, treatment options are restricted to only a few antifungal drug classes [9].”
Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825 · cited 3×
“Other common Candida species, including C. albicans, C. tropicalis, C. glabrata and C. lusitaniae, generally were most susceptible to micafungin among the three echinocandins, while C. krusei and C. pelliculasa most susceptible to anidulafungin [41,43,44,47].”
Stimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins
Walker, L. A., Munro, C. A., de Bruijn, I., Lenardon, M. D., McKinnon, A., & Gow, N. A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000040 · Cited by 445 · cited 2×
“Previous studies have shown that Candida species can rapidly respond to echinocandin treatment with a compensatory elevation in chitin content; this response protects the yeast cells from cell wall damage that would occur due to the inhibition of β -1,3-D-glu-can synthesis [39,40].”
Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01901-07 · Cited by 387 · cited 1×
“Other common Candida species, including C. albicans, C. tropicalis, C. glabrata and C. lusitaniae, generally were most susceptible to micafungin among the three echinocandins, while C. krusei and C. pelliculasa most susceptible to anidulafungin [41,43,44,47].”
Current Concepts in Antifungal Pharmacology
Lewis, R. E. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0247 · Cited by 377 · cited 1×
“Due to the large molecular weight and low oral bioavailability of echino-candins, they can only be administered intravenously, and this route of administration makes the blood the site of the highest drug concentration among human tissues [51].”
Cited by
Daneshnia, F., de Almeida Júnior, J. N., Ilkit, M., Lombardi, L., Perry, A. M., Gao, M., Nobile, C. J., Egger, M., Perlin, D. S., Zhai, B., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00067-8 · Cited by 257
Self-citationHoenigl, M., Arastehfar, A. A., Arendrup, M. C., Brüggemann, R. J. M., Carvalho, A., Chiller, T. M., Chen, W., Egger, M., Feys, S., Gangneux, J., et al. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-23 · Cited by 184
Branco, J., Miranda, I. M., & Rodrigues, A. G. (2023) · Journal of Fungi · doi:10.3390/jof9010080 · Cited by 164
Arendrup, M. C., Arıkan-Akdağlı, S., Jørgensen, K. M., Barac, A. M., Steinmann, J., Toscano, C., Arsić-Arsenijević, V. S., Sartor, A., Lass‐Flörl, C., Hamprecht, A. G., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.08.001 · Cited by 154
Epidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
Metadata
- Authors
- Ning, Y., Xiao, M., Perlin, D. S., Zhao, Y., Lu, M., Li, Y., Luo, Z., Dai, R., Li, S., Xu, J., Liu, L., He, H., Liu, Y., Li, F., Guo, Y., Chen, Z., Xu, Y., Sun, T., & Zhang, L.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Hackensack Meridian Health (US)
- Zhejiang Chinese Medical University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Second Military Medical University (CN)
- First Hospital of China Medical University (CN)
- Liaoning Provincial People's Hospital (CN)
- Tongji Hospital (CN)
- Corresponding author
- Chen, Zhongju
- Xu, Yingchun
- Sun, Tianshu
- Zhang, Li
- ORCID
- Venue
- Emerging Microbes & Infections
- Publisher
- Informa UK Limited
- Published
- 2022-12-24
- Volume
- 12
- Issue
- 1
- Pages
- 2153086-2153086
- ISSN
- 2222-1751 (ISSN-L)
- PMC
- PMC9793909
- OpenAlex
- W4310184775
- Semantic Scholar
- 9dd290eb3e4fbe6e903aba0b0e0f0d8f6c17f4be
- Cited by
- 63
- References
- 54
- Citations by year
- 2026: 8 · 2025: 24 · 2024: 16 · 2023: 13 · 2022: 2
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Emerging Microbes & Infections (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2021-I2M-1-044)
- National High Level Hospital Clinical Research Funding (2022-PUMCH-A-137)
- National Natural Science Foundation of China
- National Key R&D Program of China
- Beijing Key Clinical Specialty for Laboratory Medicine-Excellent Project
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida parapsilosis, echinocandin resistance, candidemia, invasive candidiasis, caspofungin, anidulafungin, micafungin, antifungal susceptibility, CRISPR/Cas9 mutagenesis, Candida orthopsilosis, Candida metapsilosis
- MeSH terms
- Candida parapsilosis, Caspofungin, Antifungal Agents, Candidiasis, China, Humans, Microbial Sensitivity Tests, Drug Resistance, Fungal, Echinocandins, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China. https://app.cochat.ai/papers/10.1080/22221751.2022.2153086
- The paper
- Ning, Y., Xiao, M., Perlin, D. S., Zhao, Y., Lu, M., Li, Y., Luo, Z., Dai, R., Li, S., Xu, J., Liu, L., He, H., Liu, Y., Li, F., Guo, Y., Chen, Z., Xu, Y., Sun, T., & Zhang, L. (2023). Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China. Emerging Microbes & Infections. https://doi.org/10.1080/22221751.2022.2153086
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.